246 related articles for article (PubMed ID: 37766186)
1.
Wang J; Ma C; Li M; Gao X; Wu H; Dong W; Wei L
Vaccines (Basel); 2023 Sep; 11(9):. PubMed ID: 37766186
[No Abstract] [Full Text] [Related]
2. Evaluation of the Potency, Neutralizing Antibody Response, and Stability of a Recombinant Fusion Protein Vaccine for Streptococcus pyogenes.
Burlet E; HogenEsch H; Dunham A; Morefield G
AAPS J; 2017 May; 19(3):875-881. PubMed ID: 28283948
[TBL] [Abstract][Full Text] [Related]
3. A Controlled Human Infection Model of Group A
Osowicki J; Azzopardi KI; McIntyre L; Rivera-Hernandez T; Ong CY; Baker C; Gillen CM; Walker MJ; Smeesters PR; Davies MR; Steer AC
mSphere; 2019 Feb; 4(1):. PubMed ID: 30760615
[TBL] [Abstract][Full Text] [Related]
4. A brief review on Group A Streptococcus pathogenesis and vaccine development.
Castro SA; Dorfmueller HC
R Soc Open Sci; 2021 Mar; 8(3):201991. PubMed ID: 33959354
[No Abstract] [Full Text] [Related]
5. WHO/IVI global stakeholder consultation on group A Streptococcus vaccine development: Report from a meeting held on 12-13 December 2016.
Osowicki J; Vekemans J; Kaslow DC; Friede MH; Kim JH; Steer AC
Vaccine; 2018 Jun; 36(24):3397-3405. PubMed ID: 29496349
[TBL] [Abstract][Full Text] [Related]
6. Preventing rheumatic fever: M-protein based vaccine.
Tandon R
Indian Heart J; 2014; 66(1):64-7. PubMed ID: 24581098
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of group A streptococcal infections.
Henningham A; Barnett TC; Maamary PG; Walker MJ
Discov Med; 2012 May; 13(72):329-42. PubMed ID: 22642914
[TBL] [Abstract][Full Text] [Related]
8. Prospects for a group A streptococcal vaccine.
McMillan DJ; Chhatwal GS
Curr Opin Mol Ther; 2005 Feb; 7(1):11-6. PubMed ID: 15732524
[TBL] [Abstract][Full Text] [Related]
9. Clinical development strategy for a candidate group A streptococcal vaccine.
Schödel F; Moreland NJ; Wittes JT; Mulholland K; Frazer I; Steer AC; Fraser JD; Carapetis J
Vaccine; 2017 Apr; 35(16):2007-2014. PubMed ID: 28318768
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the coverage capacity of the StreptInCor candidate vaccine against Streptococcus pyogenes.
De Amicis KM; Freschi de Barros S; Alencar RE; Postól E; Martins Cde O; Arcuri HA; Goulart C; Kalil J; Guilherme L
Vaccine; 2014 Jul; 32(32):4104-10. PubMed ID: 23994376
[TBL] [Abstract][Full Text] [Related]
11. Systematic Review and Meta-analysis of the Prevalence of Group A Streptococcal
Salie T; Engel K; Moloi A; Muhamed B; Dale JB; Engel ME
mSphere; 2020 Jul; 5(4):. PubMed ID: 32669471
[TBL] [Abstract][Full Text] [Related]
12. Molecular Epidemiology of Noninvasive and Invasive Group A Streptococcal Infections in Cape Town.
Barth DD; Naicker P; Engel K; Muhamed B; Basera W; Mayosi BM; Dale JB; Engel ME
mSphere; 2019 Oct; 4(5):. PubMed ID: 31666314
[TBL] [Abstract][Full Text] [Related]
13. Group A streptococcus.
Martin JM; Green M
Semin Pediatr Infect Dis; 2006 Jul; 17(3):140-8. PubMed ID: 16934708
[TBL] [Abstract][Full Text] [Related]
14. Immunization with a streptococcal multiple-epitope recombinant protein protects mice against invasive group A streptococcal infection.
Kuo CF; Tsao N; Hsieh IC; Lin YS; Wu JJ; Hung YT
PLoS One; 2017; 12(3):e0174464. PubMed ID: 28355251
[TBL] [Abstract][Full Text] [Related]
15. Vaccine development for group A streptococcus infections and associated disease.
Batzloff MR; Sriprakash KS; Good MF
Curr Drug Targets; 2004 Jan; 5(1):57-69. PubMed ID: 14738218
[TBL] [Abstract][Full Text] [Related]
16. Proteome based mapping and reverse vaccinology techniques to contrive multi-epitope based subunit vaccine (MEBSV) against Streptococcus pyogenes.
Aslam S; Ashfaq UA; Zia T; Aslam N; Alrumaihi F; Shahid F; Noor F; Qasim M
Infect Genet Evol; 2022 Jun; 100():105259. PubMed ID: 35231667
[TBL] [Abstract][Full Text] [Related]
17. Group A Streptococcus Infections: Their Mechanisms, Epidemiology, and Current Scope of Vaccines.
Iyer V; Sagar V; Toor D; Lyngdoh V; Nongrum G; Kapoor M; Chakraborti A
Cureus; 2022 Dec; 14(12):e33146. PubMed ID: 36721580
[TBL] [Abstract][Full Text] [Related]
18. [Streptococcus pyogenes--much more than the aetiological agent of scarlet fever].
Stock I
Med Monatsschr Pharm; 2009 Nov; 32(11):408-16; quiz 417-8. PubMed ID: 19947304
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
